Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index; 63 of the 116 sources its claims cite were checked for support.

Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review

Open access
Alarcón Garavito, Germán Andrés, Gilchrist, Katie, Ciurtin, Coziana, Khanna, Sanjay, Chambers, Pinkie, McNally, Nick, Merivale, Edward, Carr, Edi, Yu, Rosamund, Vindrola-Padros, Cecilia · 2025 · Trials

Abstract

BACKGROUND: Clinical trials are essential to the development of healthcare innovations that advance life expectancy and improve quality of life. However, there exists a pronounced disparity in ethnic representation among trial participants. This imbalance, particularly in relation to minority ethnic groups, can lead to a limited understanding of how therapies affect diverse populations. The present systematic literature review (SLR) aims to identify the factors that both hinder and facilitate the participation of minority ethnic groups in clinical trials. METHODS: This review involved a systematic search of keywords across four databases: Web of Science, PubMed, CINAHL Plus and The Cochrane Library. The review was not restricted by language or study site; however, the date of publication was limited between 1st January 2017 and 1st October 2022. Studies discussing or outlining the involvement of minority ethnic groups in clinical trials, and those outlining inclusive recruitment and participation procedures were targeted. RESULTS: A total of 43 articles were included in the review. Of these, 36 articles were from the United States (US), 20 articles reported on oncology trials and 39 articles reported information from the patient's perspective. Reported barriers included a lack of researchers from minority ethnic groups implementing and conducting clinical research, inadequate funding for clinical trial efforts in geographical areas serving minority populations and a lack of awareness and education among research staff regarding which underrepresented groups to target for recruitment and the strategies to employ in reaching out to them. Several recommendations were suggested by the articles included in the review to address these barriers. Prominently, the use of patient navigators or community liaison roles was highly recommended as a way of supporting patients through the research recruitment process. The articles also highlighted the benefits of translating study materials and interventions into multiple languages and actively involving diverse communities in the development of health education materials. Lastly, leveraging technologies to address socioeconomic barriers, such as the use of virtual approaches to avoid lengthy travel, may also help to improve diversity in trials. CONCLUSIONS: Ensuring representation of minority ethnic groups in clinical trials is critical to developing therapies with generalisable efficacies. While progress has been made in enhancing outreach of wider racial groups and fortifying educational resources, there remains a pressing need to delve deeper into the obstacles impeding the recruitment of a diverse participant base, particularly in regions outside the US, where relevant studies are scarce. REGISTRATION: The review protocol was registered on PROSPERO (CRD42022368106) (1).

Overview

CoChat Summary

TL;DR

This systematic review synthesized 43 articles on barriers and enablers of clinical trial participation among adult patients from minority ethnic groups, finding that evidence is concentrated in the US and especially in oncology. It identifies mistrust, communication/language problems, socioeconomic constraints, and lack of culturally competent outreach as recurring barriers, while patient navigators, community liaisons, translated materials, and community-engaged recruitment are recurring enablers.

Key findings

  • The review included 43 articles; 36 were from the US, 20 focused on oncology trials, and 39 reported from the patient perspective.
  • Evidence quality was moderate overall: the MMAT average score was 4, and 12 articles scored below 3.
  • Reported barriers included lack of researchers from minority ethnic groups, inadequate funding in areas serving minority populations, limited staff awareness of which groups to target and how, plus implicit bias, language barriers, and socioeconomic challenges such as unstable employment, childcare, low income, and transport problems.
  • Recurrent enablers/recommendations were patient navigators or community liaisons, translation of study materials and interventions into multiple languages, involving diverse communities in health education materials, and virtual approaches to reduce travel burden.

Methods

  • Systematic review using PRISMA, with a protocol registered on PROSPERO (CRD42022368106).
  • Searches were conducted in Web of Science, PubMed, CINAHL Plus, and The Cochrane Library/CENTRAL, for studies published between 1 January 2017 and 1 October 2022, with no language or study-site restriction.
  • Included peer-reviewed empirical studies about adult minority ethnic groups’ involvement in clinical trials or inclusive recruitment/participation processes; evidence was synthesized using narrative synthesis, and study quality was appraised with the MMAT.

Limitations

  • The paper states that it was limited to empirical articles, excluding grey literature and non-empirical articles, which could have added further reflections on disparities.
  • It also states that paediatric studies were excluded, so the findings do not apply to children.
  • Evident from the text: the evidence base is heavily US-centered (36/43 articles) and sparse outside the US, so generalisability to other countries is limited (stated in the paper).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13063-025-08769-y

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The PRISMA flow diagram
Fig. 1 The PRISMA flow diagramCC BY · PubMed Central

Verification

Claims the paper makes

30 Valid · 5 Not valid · 21 Not checked · 46 Own results and interpretations

35 more claims · 8 with their cited sources checked

Create a free account to see all 102 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 39
  • It may state two separate claims as one. 43

Create a free account to see these claims.

Citations

Cites

Show all 68 references

Cited by

See all 42

Metadata

Authors
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C.
Affiliations
  • University College London (GB)
  • University College London Hospitals NHS Foundation Trust (GB)
  • Roche (United Kingdom) (GB)
Venue
Trials
Published
2025-02-22
Volume
26
Issue
1
Pages
65-65
ISSN
1745-6215 (ISSN-L)
OpenAlex
W4407820176
Cited by
42
References
68
Citations by year
2026: 32 · 2025: 10
FWCI
7.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
University College London Hospitals NHS Foundation Trust
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Social Sciences › Anthropology › Race, Genetics, and Society
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Cultural Competency in Health Care
Keywords
clinical trial participation, ethnic minorities, underrepresented groups, recruitment barriers, patient navigators, community liaison, language translation, virtual clinical trials, cancer clinical trials, patient perspectives, health equity
MeSH terms
Adult, Clinical Trials as Topic, Ethnicity, Humans, Health Knowledge, Attitudes, Practice, Minority Groups, Patient Participation, Patient Selection, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review. https://app.cochat.ai/papers/10.1186/s13063-025-08769-y
The paper
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025). Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review. Trials. https://doi.org/10.1186/s13063-025-08769-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.